全球紫杉醇注射液市場，依癌症類型、配銷通路、地理位置。

Global Paclitaxel Injection Market, By Cancer Type, By Distribution Channel, By Geography .

出版日期: 2024年02月29日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年紫杉醇注射液市值為63.4億美元，預計2031年將達到144.4億美元，2024年至2031年年複合成長率（CAGR）為12.5%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	63.4 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	12.50%	2030/2031 價值預測：	144.4 億美元

全球紫杉醇注射液市場佔有率（%），依地區，2024年

由於癌症治療的需求不斷增加，紫杉醇注射液市場在過去幾年中出現了顯著成長。紫杉醇是一種用於化療的有絲分裂抑制劑。它是在太平洋紫杉樹的樹皮中發現的。紫杉醇的作用是透過干擾微管的正常功能來阻止細胞分裂。在癌症治療中施用時，紫杉醇可防止分裂中的癌細胞分離，進一步導致細胞死亡。該藥物在對抗乳癌、卵巢癌、肺癌和後天免疫缺乏症候群（愛滋病）相關的卡波西氏肉瘤等多種癌症方面顯示出令人鼓舞的結果。隨著癌症盛行率的上升以及對含有紫杉醇注射液的化療方案的日益依賴，預計市場在預測期內將穩定成長。

市場動態：

全球紫杉醇注射液市場受到乳癌和卵巢癌發生率上升的推動。根據世界衛生組織的數據，乳癌是女性最常見的癌症，全球每年新增病例超過 200 萬例。此外，紫杉醇廣泛用於治療乳癌。此外，提高紫杉醇功效的先進技術進一步促進了市場成長。然而，替代治療藥物的可用性以及與紫杉醇注射相關的某些副作用是限制因素。開發奈米載體藥物製劑以降低毒性並改善紫杉醇的輸送為市場參與者帶來了巨大的機會。

研究的主要特點：

該報告對全球紫杉醇注射液市場進行了深入分析，並提供了預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%），以2023年為基準年。
它闡明了不同區隔市場的潛在收入成長機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數（例如公司亮點、產品組合、主要亮點、財務表現和策略）介紹了全球紫杉醇注射市場的主要參與者。
本研究涵蓋的主要公司包括百時美施貴寶公司、U & V Cancure Private Limited、輝瑞公司、綠葉製藥集團、Fresenius Kabi AG、Accord Healthcare、Viatris Inc.、Teva Pharmaceutical Industries Ltd.、Dr. Reddy's Laboratories Ltd. 、Sandoz Group AG、Salvavidas、Sun Pharmaceutical Industries Ltd.、Cipla Inc.、Alvogen、Apotex Inc. 和Bharat Parenterals Limited。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球紫杉醇注射液市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球紫杉醇注射市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東協
亞太其他地區
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
南非
北非
中非

第 7 章：公司概況 - 全球紫杉醇注射劑市場

Bristol-Myers Squibb Company
- 公司簡介
- 產品/服務組合
- 財務績效
- 最新動態/更新
- 戰略概覽
U & V Cancure Private Limited
Pfizer Inc.
Luye Pharma Group
Fresenius Kabi AG
Accord Healthcare
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sandoz Group AG
Salvavidas
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Alvogen
Apotex Inc.
Bharat Parenterals Limited

第 8 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI6704

The paclitaxel injection market is estimated to be valued at USD 6.34 Bn in 2024 and is expected to reach USD 14.44 Bn by 2031, growing at a compound annual growth rate (CAGR) of 12.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 6.34 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	12.50%	2030/2031 Value Projection:	US$ 14.44 Bn

Global Paclitaxel Injection Market Share (%), By Region, 2024

Global Paclitaxel Injection Market - IMG1

The paclitaxel injection market has witnessed significant growth in the past few years owing to its increasing demand in cancer treatment. Paclitaxel is a mitotic inhibitor used in chemotherapy. It was discovered in the bark of the Pacific Yew tree. Paclitaxel works by blocking cellular division through interfering with the normal functioning of microtubules. When administered in cancer treatment, paclitaxel prevents dividing cancer cells from separating, which further leads to cell death. The drug has shown encouraging results in fighting various types of cancers such as breast cancer, ovarian cancer, lung cancer, and Acquired Immune Deficiency Syndrome (AIDS)-related Kaposi's sarcoma. With the rising prevalence of cancer and increasing reliance on chemotherapy regimens containing paclitaxel injection, the market is expected to grow steadily over the forecast period.

Market Dynamics:

The global paclitaxel injection market is driven by the rising incidence of breast cancer and ovarian cancer. As per the World Health Organization, breast cancer is the most common cancer among women, with over 2 million new cases annually across the globe. Moreover, paclitaxel is extensively used in treating breast cancer. Additionally, advancing technologies for increasing the efficacy of paclitaxel are further augmenting the market growth. However, the availability of alternative treatment drugs and certain side-effects associated with paclitaxel injection are restraining factors. The development of nano-carrier drug formulations to reduce toxicity and improve paclitaxel delivery holds significant opportunities for market players.

Key Features of the Study:

This report provides an in-depth analysis of the global paclitaxel injection market, and provides market size (USD Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global paclitaxel injection market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Bristol-Myers Squibb Company, U & V Cancure Private Limited, Pfizer Inc., Luye Pharma Group, Fresenius Kabi AG, Accord Healthcare, Viatris Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sandoz Group AG, Salvavidas, Sun Pharmaceutical Industries Ltd., Cipla Inc., Alvogen, Apotex Inc., and Bharat Parenterals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global paclitaxel injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global paclitaxel injection market

Detailed Segmentation:

By Cancer Type:
- Breast Cancer
- Gastric Cancer
- Pancreatic Cancer
- Non-small Cell Lung Cancer
- Ovarian Cancer
- Kaposi sarcoma
- Others
By Distribution Channel:
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Bristol-Myers Squibb Company
- U & V Cancure Private Limited
- Pfizer Inc.
- Luye Pharma Group
- Fresenius Kabi AG
- Accord Healthcare
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Reddy's Laboratories Ltd.
- Sandoz Group AG
- Salvavidas
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- Alvogen
- Apotex Inc.
- Bharat Parenterals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Cancer Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
- Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition, and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Regulatory Scenario
Pricing Analysis
Product Recalls
Pipeline Analysis

4. Global Paclitaxel Injection Market, By Cancer Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Breast Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Gastric Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Pancreatic Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Non-small Cell Lung Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Ovarian Cancer, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Kaposi sarcoma, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Paclitaxel Injection Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Paclitaxel Injection Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2024 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
Asean
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Cancer Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

7. Company Profiles - Global Paclitaxel Injection Market

Bristol-Myers Squibb Company*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
U & V Cancure Private Limited
Pfizer Inc.
Luye Pharma Group
Fresenius Kabi AG
Accord Healthcare
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Sandoz Group AG
Salvavidas
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
Alvogen
Apotex Inc.
Bharat Parenterals Limited